Metraipolis › archive › dc_51121bc4e53a

Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis — Europe PMC PMID:41304918

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304918
DOI
10.3390/ph18111674
License (as archived)
solo-consultazione
Archived
2026-11-08T19:08:49.154Z
SHA-256 of the archived text
94dfb5883d94bf57a7a3360d405f7ade5440b24cb70684f9a01cfe544f5afab7
Stable URL of this page
https://metraipolis.com/documento/dc_51121bc4e53a

How to cite

Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis — Europe PMC PMID:41304918 — Europe PMC (en), https://europepmc.org/article/MED/41304918 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_51121bc4e53a (Metraipolis archive dc_51121bc4e53a, sha256 94dfb5883d94bf57a7a3360d405f7ade5440b24cb70684f9a01cfe544f5afab7)
BibTeX
@misc{dc51121bc4e53a,
  title = {Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis — Europe PMC PMID:41304918},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304918},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_51121bc4e53a; sha256 94dfb5883d94bf57a7a3360d405f7ade5440b24cb70684f9a01cfe544f5afab7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304918. Agents can read the archived copy with the MCP tool read_document.